Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function

European Journal of Immunology

Volumn 34, Issue 11, 2004, Pages 2996-3005

  Tang, Qizhi ^a   Boden, Elisa K ^a   Henriksen, Kammi J ^a   Bour Jordan, Helene ^a   Bi, Mingying ^a   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Costimulation; Cytokines; T lymphocytes; Tolerance suppression anergy

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; HOMEOSTASIS; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SCIENTIFIC LITERATURE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; INTERLEUKIN-10; L-SELECTIN; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFORMING GROWTH FACTOR BETA;

EID: 9244261022     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425143     Document Type: Article

References (46)

1. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000. 164: 183-190.
2. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
3. Piccirillo, C. A., Letterio, J. J., Thornton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H. and Shevach, E. M., CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 2002. 196: 237-246.
4. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. and Schuler, G., Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 2001. 193: 1303-1310.
5. Apostolou, I., Sarukhan, A., Klein, L. and von Boehmer, H., Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 2002. 3: 756-763.
6. Levings, M. K., Sangregorio, R. and Roncarolo, M. G., Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001. 193: 1295-1302.
7. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
8. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 1335-1346.
9. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. and Powrie, F., An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 1999. 190: 995-1004.
10. Read, S., Malmstrom, V. and Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000. 192: 295-302.
11. + regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 2002. 168: 1080-1086.
12. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
13. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995. 270: 985-988.
14. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
15. Tivol, E. A. and Gorski, J., Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 2002. 169: 1852-1858.
16. Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W. and Kopf, M., Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 1999. 163: 1128-1131.
17. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W. and Sakaguchi, S., Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000. 192: 303-310.
18. Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B. and Sharpe, A. H., CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 1997. 158: 5091-5094.
19. Yamamoto, A. M., Chernajovsky, Y., Lepault, F., Podhajcer, O., Feldmann, M., Bach, J. F. and Chatenoud, L., The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy. J. Immunol. 2001. 166: 4973-4980.
20. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
21. + regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
22. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
23. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000. 12: 431-440.
24. + regulatory T cells. J. Immunol. 2003. 171: 3348-3352.
25. Chen, W., Jin, W. and Wahl, S. M., Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J. Exp. Med. 1998. 188: 1849-1857.
26. Nakamura, K., Kitani, A. and Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001. 194: 629-644.
27. Sullivan, T. J., Letterio, J. J., van Elsas, A., Mamura, M., van Amelsfort, J., Sharpe, S., Metzler, B., Chambers, C. A. and Allison, J. P., Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 2001. 98: 2587-2592.
28. Khalil, N., TGF-beta: from latent to active. Microbes Infect. 1999. 1: 1255-1263.
29. Ghahary, A., Tredget, E. E., Mi, L. and Yang, L., Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Exp. Cell Res. 1999. 251: 111-120.
30. Godar, S., Horejsi, V., Weidle, U. H., Binder, B. R., Hansmann, C. and Stockinger, H., M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur. J. Immunol. 1999. 29: 1004-1013.
31. Odekon, L. E., Blasi, F. and Rifkin, D. B., Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J. Cell Physiol. 1994. 158: 398-407.
32. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
33. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A., CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996. 183: 2541-2550.
34. McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M. and Byrne, M. C., CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002. 16: 311-323.
35. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. and Sakaguchi, S., Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002. 3: 135-142.
36. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C. and Puccetti, P., CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 2002. 3: 1097-1101.
37. Finger, E. B. and Bluestone, J. A., When ligand becomes receptor-tolerance via B7 signaling on DCs. Nat. Immunol. 2002. 3: 1056-1057.
38. Bluestone, J. A. and Abbas, A. K., Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003. 3: 253-257.
39. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. and Levings, M. K., Type 1 T regulatory cells. Immunol. Rev. 2001. 182: 68-79.
40. Levings, M. K., Bacchetta, R., Schulz, U. and Roncarolo, M. G., The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 2002. 129: 263-276.
41. + regulatory T cell subsets. J. Leukoc. Biol. 2003. 74: 471-478.
42. + regulatory T cells in the steady state. J. Exp. Med. 2003. 198: 737-746.
43. Chen, W. and Wahl, S. M., TGF-beta: the missing link in CD4(+)CD25(+) regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. 2003. 14: 85-89.
44. Fuss, I. J., Boirivant, M., Lacy, B. and Strober, W., The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J. Immunol. 2002. 168: 900-908.
45. + T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol. 1998. 160: 5719-5728.
46. Bour-Jordan, H., Grogan, J. L., Tang, Q., Auger, J. A., Locksley, R. M. and Bluestone, J. A., CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat. Immunol. 2003. 4: 182-188.